APA (7th ed.) Citation

JS, S., L, E., PC, A., A, A., SK, B., D, B., . . . O, S. (2026). Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer. Journal of medicinal chemistry, 69(3), 3209. https://doi.org/10.1021/acs.jmedchem.5c03138

Chicago Style (17th ed.) Citation

JS, Scott, et al. "Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer." Journal of Medicinal Chemistry 69, no. 3 (2026): 3209. https://doi.org/10.1021/acs.jmedchem.5c03138.

MLA (9th ed.) Citation

JS, Scott, et al. "Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer." Journal of Medicinal Chemistry, vol. 69, no. 3, 2026, p. 3209, https://doi.org/10.1021/acs.jmedchem.5c03138.